Provided by Tiger Fintech (Singapore) Pte. Ltd.

Corcept Therapeutics

70.41
-0.8300-1.17%
Volume:394.06K
Turnover:27.80M
Market Cap:7.47B
PE:61.63
High:72.00
Open:71.24
Low:69.47
Close:71.24
Loading ...

Corcept (CORT) Q4 Earnings Report Preview: What To Look For

StockStory
·
25 Feb

Should Janus Henderson Small Cap Growth Alpha ETF (JSML) Be on Your Investing Radar?

Zacks
·
25 Feb

Corcept Therapeutics Inc expected to post earnings of 43 cents a share - Earnings Preview

Reuters
·
25 Feb

Corcept Therapeutics Incorporated (CORT): the Best Performing Pharma Stock So Far in 2025

Insider Monkey
·
24 Feb

Is Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF (GSSC) a Strong ETF Right Now?

Zacks
·
18 Feb

Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2024 Financial Results, Provide Corporate Update and Host Conference Call

Business Wire
·
13 Feb

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
12 Feb

5 Balance Sheet Powerhouses To Consider

GuruFocus.com
·
11 Feb

Corcept Therapeutics Price Target Maintained With a $80.00/Share by HC Wainwright & Co.

Dow Jones
·
07 Feb

Corcept Therapeutics: Leveraging Korlym Growth and CATALYST Study for Market Expansion and Long-term Growth

TIPRANKS
·
07 Feb

3 US Growth Companies With High Insider Ownership Expecting Up To 22% Revenue Growth

Simply Wall St.
·
05 Feb

Zacks Industry Outlook Highlights Corcept, Amneal, Dyne, Nektar and Cardiol

Zacks
·
03 Feb

Corcept (CORT) Soars 13.6%: Is Further Upside Left in the Stock?

Zacks
·
31 Jan

5 Small Drug Stocks to Add to Your Kitty in the Trump 2.0 Era

Zacks
·
31 Jan

Should Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF (GSSC) Be on Your Investing Radar?

Zacks
·
31 Jan

Corcept Therapeutics Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
31 Jan

Top Stock Reports for American Express, Lockheed Martin & Constellation Energy

Zacks
·
30 Jan

All You Need to Know About Corcept (CORT) Rating Upgrade to Strong Buy

Zacks
·
30 Jan

Buy These 5 Stocks With Recent Price Strength Amid a Volatile January

Zacks
·
29 Jan

Corcept Therapeutics Incorporated (CORT) Hit a 52 Week High, Can the Run Continue?

Zacks
·
24 Jan